Advertisement
U.S. markets open in 2 hours 50 minutes

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
67.62+1.62 (+2.45%)
At close: 04:00PM EDT
67.62 0.00 (0.00%)
After hours: 05:39PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
1.42B1.13B1.18B1.09B714.66M702.17M
Enterprise Value
1.51B1.24B1.33B1.34B977.80M957.47M
Trailing P/E
79.55102.11N/AN/AN/AN/A
Forward P/E
14.9013.5314.5821.1017.3312.08
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.532.142.422.452.042.23
Price/Book (mrq)
3.292.622.893.472.282.26
Enterprise Value/Revenue
3.119.4510.0611.469.1610.16
Enterprise Value/EBITDA
14.2056.8440.0649.3939.8155.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 369.69%
S&P500 52-Week Change 328.64%
52 Week High 370.50
52 Week Low 336.54
50-Day Moving Average 359.20
200-Day Moving Average 356.51

Share Statistics

Avg Vol (3 month) 3134.94k
Avg Vol (10 day) 3198.9k
Shares Outstanding 521.07M
Implied Shares Outstanding 621.07M
Float 814.67M
% Held by Insiders 110.23%
% Held by Institutions 175.16%
Shares Short (Feb 29, 2024) 4249.12k
Short Ratio (Feb 29, 2024) 42.13
Short % of Float (Feb 29, 2024) 41.75%
Short % of Shares Outstanding (Feb 29, 2024) 41.18%
Shares Short (prior month Jan 31, 2024) 4242.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 18, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 3.86%
Operating Margin (ttm)6.62%

Management Effectiveness

Return on Assets (ttm)3.72%
Return on Equity (ttm)4.72%

Income Statement

Revenue (ttm)486.82M
Revenue Per Share (ttm)27.04
Quarterly Revenue Growth (yoy)39.70%
Gross Profit (ttm)N/A
EBITDA 109.32M
Net Income Avi to Common (ttm)15.47M
Diluted EPS (ttm)0.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)221.12M
Total Cash Per Share (mrq)11.22
Total Debt (mrq)291.34M
Total Debt/Equity (mrq)63.67%
Current Ratio (mrq)3.57
Book Value Per Share (mrq)22.64

Cash Flow Statement

Operating Cash Flow (ttm)118.96M
Levered Free Cash Flow (ttm)112.78M